Geneticists

We streamline decision-making with accurate variant detection, simplified prioritization, and expedited reporting across any genomics analysis workflow.

Eliminating bottlenecks in genomics analysis

Rising volumes of complex NGS sequencing data demand advanced analytical tools that integrate into any genomics lab workflow. Geneticists need accurate and automated approaches to confidently detect rare and challenging variants from large datasets.

Our mission is to leverage our expertise in rare disorders and cutting-edge technology to reduce turnaround times and provide actionable insights. Our platform enhances NGS data analytics, pinpointing signals amongst the noise for faster, more informed decision-making.

Access best-in-class NGS data analytics

Benefit from AI-powered algorithms for accurate genomic analysis.

Pinpoint rare and complex variants with ease

Accelerate variant prioritization, interpretation, and reporting.

Gain insights from a community of experts

Flag important findings and join disease-specific peer networks.

Enhance genomic analysis with SOPHiA DDM™

Expedite insights from NGS data

SOPHiA DDM™ for Genomics uses advanced AI algorithms to detect, annotate, and pre-classify genomic variants from complex and noisy NGS sequencing data.

Knowledge sharing across the SOPHiA GENETICS network supports faster, more confident decision-making for Rare & Inherited Disorders.

SOPHiA DDM™ for Genomics

Alamut™ Visual Plus

Gain new insights into complex conditions with our full genome browser displaying comprehensive information from >55 trusted, curated data sources in one place.

Learn More

Featured Resources

CASE STUDY

Implementing comprehensive clinical exome analysis at Henry Ford Health: Hereditary cancer, cystic fibrosis, and pharmacogenetics applications

Blog

Tech Talk: Achieve sensitive and precise CNV calling with SOPHiA DDM™ Platform

Webinar

Optimized variant prioritization for enhanced insights

Blog

Customer Spotlight: Katherine Lafferty at Broad Clinical Labs

APP Note

Neurological Disorders Application Note

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview

SOPHiA DDM™ for Genomics

SOPHiA DDM™ for Radiomics

SOPHiA DDM™ for Multimodal

Professional Services